The stock of Adeptus Health Incorporated (NYSE:ADPT) registered a decrease of 1.99% in short interest. ADPT’s total short interest was 7.15M shares in September as published by FINRA. Its down 1.99% from 7.30M shares, reported previously. With 254,600 shares average volume, it will take short sellers 28 days to cover their ADPT’s short positions. The short interest to Adeptus Health Incorporated’s float is 79.06%. About 461,144 shares traded hands or 1.10% up from the average. Adeptus Health Inc (NYSE:ADPT) has declined 11.02% since February 8, 2016 and is downtrending. It has underperformed by 27.51% the S&P500.
Adeptus Health Inc. is a patient-centered healthcare company. The company has a market cap of $840.90 million. The Firm is engaged in providing emergency medical care through a network of independent freestanding emergency rooms in the United States and partnerships with various healthcare systems. It has a 6.29 P/E ratio. The Firm has approximately 80 freestanding facilities and over two licensed general hospitals.
The institutional sentiment increased to 1.96 in Q2 2016. Its up 0.04, from 1.92 in 2016Q1. The ratio is positive, as 29 funds sold all Adeptus Health Inc shares owned while 25 reduced positions. 22 funds bought stakes while 84 increased positions. They now own 21.33 million shares or 18.77% more from 17.95 million shares in 2016Q1.
Tpg holds 10.94% of its portfolio in Adeptus Health Inc for 1.47 million shares. Sectoral Asset Management Inc owns 619,108 shares or 3.3% of their US portfolio. Moreover, Deerfield Management Co has 3.25% invested in the company for 1.60 million shares. The New York-based Atika Capital Management Llc has invested 2.77% in the stock. Granite Point Capital Management L.P., a Massachusetts-based fund reported 100,650 shares.
Out of 5 analysts covering Adeptus Health (NYSE:ADPT), 5 rate it a “Buy”, 0 “Sell”, while 0 “Hold”. This means 100% are positive. Adeptus Health has been the topic of 8 analyst reports since September 18, 2015 according to StockzIntelligence Inc. JMP Securities maintained the stock on August 31 with “Market Outperform” rating.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.